Referral and Intial Evaluation Process

Total: 7 results found.

Search for:
Search Only:

1. SNM 2012 Image of the Year: Bi-213-DOTATOC for a New Treatment for GEP-NET Tumors Resistant to Standard Therapies:
(In the News)
Miami Beach, Fla. – The Society of Nuclear Medicine's (SNM) 2012 Image of the Year illustrates the effectiveness of Bi-213-DOTATOC for the peptide receptor alpha-therapy of gastroenteropancreatic neuroendocrine ...
Created on 20 June 2012
2. Updates from the Ga68 Working Group
(News)
... trials. In October 2013, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) received orphan drug designation for Ga-68 DOTATOC. Click hereto see the slides from the Gallium Information Session ...
Created on 18 August 2014
3. Ga68 - Orphan Drug Announcement
(In the News)
BREAKING NEWS – the radiopharmaceutical Gallium-68 (DOTA0-hel-Tyr3) octreotide (Ga-68 DOTATOC) has been designated as an orphan drug by the US Food and Drug Administration (FDA) for the management of neuroendocrine ...
Created on 20 November 2013
4. Susan's Stor
(Bad Berka)
... more in one week about my carcinoid than we had in the previous 10 years. This was mostly due to the Gallium-68 DOTATOC PET/CT Scan and Dr. Baum's experience in treating over 1,000 patients. The scan ...
Created on 28 January 2012
5. Road to Basel - Terry Y.
(Basel)
... days stay PRRT injection cost: 6000 CHF (Y90 DOTATOC) Total: 9240 CHF (CHF – Canton Helvetica Franc -- is the notation for Swiss currency. Switzerland is not a European Union country. Therefore, ...
Created on 12 June 2011
6. 1st World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy
(In the News)
1st World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy THERANOSTICS – on the Way to Personalized Medicine Since 1997, when he first used the radiolabeled peptide Y-90 DOTATOC (a somatostatin ...
Created on 07 April 2011
7. Information for Referring Physicians
(General MD)
... by OctreoScan or (preferable) by Ga-68 DOTATOC PET/CT. * Renal function and blood counts should be in the normal range. * Small bowel tumors (midgut), progressive under octreotide (Sandostatin, Somatuline) ...
Created on 19 July 2010